Bansi Nagji - Oct 7, 2021 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
President, Healthcare
Signature
/s/ Gracye Cheng, as Attorney-in-Fact for Bansi Nagji
Stock symbol
GDRX
Transactions as of
Oct 7, 2021
Transactions value $
-$137,563
Form type
4
Date filed
10/12/2021, 09:32 PM
Previous filing
Sep 16, 2021
Next filing
Oct 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise $24.6K +3.6K +12.34% $6.84 32.8K Oct 7, 2021 Direct
transaction GDRX Class A Common Stock Sale -$162K -3.6K -10.99% $45.05* 29.2K Oct 7, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Stock Option (Right to Buy) Options Exercise $0 -3.6K -50% $0.00 3.6K Oct 7, 2021 Class A Common Stock 3.6K $6.84 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024.
F4 The Reporting Person's prior Form 4 filed on September 16, 2021 incorrectly stated that 309,564 shares underlying this option remained after the reported transactions and should have reported 309,584 shares underlying this option after the reported transactions.